Sumitomo Mitsui Trust Holdings, Inc.

13F Holdings History for Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT)

Symbol: ARCT on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 1.95M shares
Security Ownership: 7.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Sumitomo Mitsui Trust Group, Inc. ownership in Arcturus Therapeutics Holdings Inc. Common Stock, par value $0.001 per share (ARCT)

2025-10-27 - Sumitomo Mitsui Trust Group, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.95M shares of Arcturus Therapeutics Holdings Inc. Common Stock, par value $0.001 per share (ARCT). This represents 7.2% percent ownership of the company. In their previous filing dated 2025-04-25, Sumitomo Mitsui Trust Holdings, Inc. had reported owning 1.93M shares, indicating an increase of 1.13% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Sumitomo Mitsui Trust Group, Inc.	7.2%	+1.43%	$35.9M	1.95M	+21,751	+1.13%	$18.43	13G/A	9/30/2025	27 Oct 2025 06:57:10
Sumitomo Mitsui Trust Group, Inc.	7.1%		$18.9M	1.93M			$9.82	13G/A	3/31/2025	25 Apr 2025 06:18:10

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.02%	+0%	$35.9M	1.95M	+115,368	+6.3%	$18.43	Q3 2025
6/30/2025	0.01%	0%	$23.8M	1.83M	-93,617	-4.86%	$13.01	Q2 2025
3/31/2025	0.01%	0%	$20.4M	1.93M	-138,966		$10.59	Q1 2025
12/31/2024	0.02%	0%	$35M	2.07M	-210,665	-9.26%	$16.97	Q4 2024
9/30/2024	0.04%	+0.01%	$52.8M	2.28M	+712,650	+45.6%	$23.21	Q3 2024
6/30/2024	0.03%	+0%	$38.1M	1.56M	+286,546	+22.4%	$24.35	Q2 2024
3/31/2024	0.03%	0%	$43.1M	1.28M	-44,133	-3.34%	$33.77	Q1 2024
12/31/2023	0.03%	0%	$41.6M	1.32M	-67,922	-4.89%	$31.53	Q4 2023
9/30/2023	0.03%	0%	$35.5M	1.39M	-16,358	-1.16%	$25.55	Q3 2023
6/30/2023	0.03%	0%	$40.3M	1.4M	-16,393	-1.15%	$28.68	Q2 2023
3/31/2023	0.03%	0%	$34.1M	1.42M	-27,735	-1.91%	$23.97	Q1 2023
12/31/2022	0.02%	0%	$24.6M	1.45M	-10,355	-0.71%	$16.96	Q4 2022
9/30/2022	0.02%	+0%	$21.6M	1.46M	+23,221	+1.62%	$14.82	Q3 2022
6/30/2022	0.02%	+0%	$22.6M	1.44M	+34,116	+2.43%	$15.74	Q2 2022
3/31/2022	0.03%	+0%	$37.8M	1.4M	+44,606	+3.29%	$26.96	Q1 2022
12/31/2021	0.03%	0%	$50.2M	1.36M	-1,060	-0.08%	$37.01	Q4 2021
9/30/2021	0.04%	+0%	$64.9M	1.36M	+143,631	+11.8%	$47.78	Q3 2021
6/30/2021	0.02%	+0.02%	$41.1M	1.21M	+899,089	+285%	$33.84	Q2 2021
3/31/2021	0.01%	+0%	$13M	316K	+181,208	+135%	$41.30	Q1 2021
12/31/2020	0%	+0%	$5.84M	135K	+3,434	+2.62%	$43.38	Q4 2020
9/30/2020	0%	0%	$5.63M	131K	-15,182	-10.4%	$42.90	Q3 2020
6/30/2020	0%	0%	$6.84M	146K	-108,714	-42.6%	$46.74	Q2 2020
3/31/2020	0%	0%	$3.47M	255K	-25,482	-9.08%	$13.59	Q1 2020
12/31/2019	0%	0%	$3.05M	281K	-17,982	-6.02%	$10.87	Q4 2019
9/30/2019	0%	+0%	$3.07M	299K	+168,556	+130%	$10.27	Q3 2019
6/30/2019	0%	+0%	$1.23M	130K	+129,974	NEW	$9.44	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.